Daesung Microbiological Labs. Statistics

Total Valuation

Daesung Microbiological Labs. has a market cap or net worth of KRW 34.77 billion. The enterprise value is 47.91 billion.

Market Cap	34.77B
Enterprise Value	47.91B

Important Dates

The next estimated earnings date is Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Daesung Microbiological Labs. has 3.80 million shares outstanding. The number of shares has increased by 0.25% in one year.

Current Share Class	n/a
Shares Outstanding	3.80M
Shares Change (YoY)	+0.25%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	38.60%
Owned by Institutions (%)	n/a
Float	2.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.44
PB Ratio	1.01
P/TBV Ratio	1.02
P/FCF Ratio	72.39
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 122.71, with an EV/FCF ratio of 99.76.

EV / Earnings	-17.12
EV / Sales	1.98
EV / EBITDA	122.71
EV / EBIT	n/a
EV / FCF	99.76

Financial Position

The company has a current ratio of 3.62, with a Debt / Equity ratio of 0.65.

Current Ratio	3.62
Quick Ratio	1.92
Debt / Equity	0.65
Debt / EBITDA	52.07
Debt / FCF	46.76
Interest Coverage	-2.63

Financial Efficiency

Return on equity (ROE) is -7.75% and return on invested capital (ROIC) is -2.55%.

Return on Equity (ROE)	-7.75%
Return on Assets (ROA)	-2.44%
Return on Capital (ROIC)	-2.55%
Revenue Per Employee	180.33M
Profits Per Employee	-20.89M
Employee Count	134
Asset Turnover	0.39
Inventory Turnover	1.74

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-17.86%
50-Day Moving Average	9,705.80
200-Day Moving Average	10,184.50
Relative Strength Index (RSI)	42.09
Average Volume (20 Days)	18,220

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Daesung Microbiological Labs. had revenue of KRW 24.16 billion and -2.80 billion in losses. Loss per share was -736.04.

Revenue	24.16B
Gross Profit	2.88B
Operating Income	-2.42B
Pretax Income	-3.02B
Net Income	-2.80B
EBITDA	431.33M
EBIT	-2.42B
Loss Per Share	-736.04

Full Income Statement

Balance Sheet

The company has 9.31 billion in cash and 22.46 billion in debt, giving a net cash position of -13.14 billion or -3,459.07 per share.

Cash & Cash Equivalents	9.31B
Total Debt	22.46B
Net Cash	-13.14B
Net Cash Per Share	-3,459.07
Equity (Book Value)	34.31B
Book Value Per Share	9,027.97
Working Capital	18.17B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.56 billion and capital expenditures -1.08 billion, giving a free cash flow of 480.32 million.

Operating Cash Flow	1.56B
Capital Expenditures	-1.08B
Free Cash Flow	480.32M
FCF Per Share	126.40

Full Cash Flow Statement

Margins

Gross margin is 11.91%, with operating and profit margins of -10.03% and -11.58%.

Gross Margin	11.91%
Operating Margin	-10.03%
Pretax Margin	-12.51%
Profit Margin	-11.58%
EBITDA Margin	1.79%
EBIT Margin	-10.03%
FCF Margin	1.99%

Dividends & Yields

Daesung Microbiological Labs. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.25%
Shareholder Yield	-0.25%
Earnings Yield	-8.04%
FCF Yield	1.38%

Dividend Details

Stock Splits

The last stock split was on April 25, 2018. It was a forward split with a ratio of 10.

Last Split Date	Apr 25, 2018
Split Type	Forward
Split Ratio	10

Scores

Daesung Microbiological Labs. has an Altman Z-Score of 2.19. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.19
Piotroski F-Score	n/a